Autonomic Nervous System PDF
Document Details
Uploaded by FriendlyTrust
University of KwaZulu-Natal - Westville
Tags
Summary
These notes provide a comprehensive overview of the autonomic nervous system (ANS), covering its structure, function, divisions (sympathetic and parasympathetic), and key neurotransmitters. The document details the organization of the ANS, discussing preganglionic and postganglionic neurons and the roles of different neurotransmitters in mediating various physiological responses.
Full Transcript
**The Autonomic Nervous System (ANS)** The ANS is part of the **peripheral nervous system (PNS)** and includes: - **Sympathetic Division (SNS):** Prepares the body for \"fight or flight\" responses. - **Parasympathetic Division (PNS):** Manages \"rest and digest\" activities. The ANS...
**The Autonomic Nervous System (ANS)** The ANS is part of the **peripheral nervous system (PNS)** and includes: - **Sympathetic Division (SNS):** Prepares the body for \"fight or flight\" responses. - **Parasympathetic Division (PNS):** Manages \"rest and digest\" activities. The ANS works automatically (without conscious effort) and coordinates with the endocrine system to maintain homeostasis. - **Parabrachial nuclei** (behavioral response to taste- hence role in conditioning) - **reticular formation** - **Hypothalamus** - **PAG\*\*→ medullary** - **Amygdala** **Organization of the ANS** The ANS operates through two main neuron chains: 1. **Preganglionic Neurons** (from the CNS to a ganglion). 2. **Postganglionic Neurons** (from the ganglion to the target organ). These neurons control organ functions based on inputs from the brain, spinal cord, and sensory information. **Sympathetic Division (SNS)** - **Preganglionic neurons:** Originate in the spinal cord **(T1-L3)** and travel to the sympathetic ganglia. - **-** **Preganglionic fibers emerge as spinal nerves T1 -- L3. and project via white rami (type B, myelinated) to the paravertebral ganglia/ sympathetic chain (bilateral). At this junction/synapse → NT is ACh.** - **-** **Exceptions:** - **Postganglionic fibers (type C) -- projects to effectors (long)** - **Other ganglia in sympathetic chain** - **Postganglionic neurons:** Send signals to organs and tissues, often causing a widespread response. - **Neurotransmitters:** Norepinephrine (NE) is the primary transmitter in postganglionic fibers, targeting **adrenergic receptors** (α and β) on tissues. - **Adrenal Medulla:** Functions like a postganglionic neuron, releasing NE and epinephrine into the bloodstream for a powerful, sustained response. **Parasympathetic Division** - Nuclei located at 2 points : 1\) **Brain stem** where there are **4 nuclei viz:** i. **Edinger-Westphal,** ii. **Salivatory(superior),** iii. **Salivatory(inferior) &** iv. **Dorsal motor nucleus of vagus nerve** v. **Motor output of these nuclei via cranial nerves 3,4,7,9,10** 2**) Sacral area** (lateral gray matter) Output via spinal nerves **S2-S4** hence craniosacral outflow - **Preganglionic neurons:** Start in the brainstem or sacral spinal cord and travel to ganglia near or within the target organs. - **Postganglionic neurons:** Shorter, directly innervating target organs for more specific responses. - **Neurotransmitters:** Acetylcholine (ACh) is used by both pre- and postganglionic neurons, acting on **cholinergic receptors** (muscarinic and nicotinic). - **Changes in receptor density alters sensitivity** **ANS Action** - **Balance of SNS and PNS:** At rest, both divisions are active, maintaining a \"tone\" that can shift depending on the body\'s needs. - Other important characteristics: - **1) Responses often occur in anticipation of a disturbance**. - **2) Activity of ANS linked to activity of somatic NS** - Eg. **regulation of BP from supine to standing upright rapidly (orthostatic hypotension)** - Dysautonomia - **Sympathetic activation:** Increases heart rate, blood pressure, and prepares the body for physical activity. - **Parasympathetic activation:** Lowers heart rate, enhances digestion, and supports energy storage. **Receptors and Signal Transduction in the ANS** - **Cholinergic Receptors:** Respond to ACh, divided into: - **Nicotinic receptors (N1, N2):** Found in ganglia, **initiating rapid responses.** - Nicotinic receptors are activated by the binding of acetylcholine (ACh), a neurotransmitter released by nerve terminals. - Upon binding of ACh, the receptor undergoes a conformational change, opening its ion channel pore. - This allows the influx of sodium (Na+) and calcium (Ca2+) ions into the cell, leading to depolarization of the cell membrane. - Depolarization triggers an action potential, which propagates along the nerve or muscle fiber. - **Muscarinic receptors (M1-M5):** Located on target organs, **mediating slower, complex responses.** **Activation of Phospholipase C:** The activated G protein stimulates **the enzyme phospholipase C (PLC).** **Production of Second Messengers:** PLC **cleaves phosphatidylinositol 4,5-bisphosphate (PIP2)** into two second messengers: - **Inositol trisphosphate (IP3)** - **Diacylglycerol (DAG)** **Cellular Responses:** - IP3 binds to receptors on the **endoplasmic reticulum**, **causing the release of calcium ions (Ca2+) into the cytosol.** Increased intracellular Ca2+ can lead to various cellular responses, such as muscle contraction, secretion, and changes in gene expression. - **DAG activates protein kinase C (PKC),** which phosphorylates various proteins, leading to a wide range of cellular responses - **Adrenergic Receptors:** Respond to NE and epinephrine, classified as: - **Alpha receptors (α1, α2):** Regulate functions like blood vessel constriction. - **Beta receptors (β1, β2, β3):** Involved in heart rate modulation, airway dilation, and energy mobilization. - α1-adrenergic receptors are GPCRs, meaning they have **seven transmembrane domains.** - They are named after their affinity for the neurotransmitter norepinephrine (NE), also known as noradrenaline. - α1-adrenergic receptors are activated by the binding of NE, which is released by sympathetic nerve terminals. - Upon binding of NE, the receptor undergoes a conformational change, which activates the associated Gq protein. - The activated Gq protein then initiates a signaling cascade that leads to various cellular responses. 1. **Activation of Phospholipase C**: The activated Gq protein stimulates the enzyme phospholipase C (PLC). 2. **Production of Second Messengers**: PLC cleaves phosphatidylinositol 4,5-bisphosphate (PIP2) into two second messengers: - Inositol trisphosphate (IP3) - Diacylglycerol (DAG) 3. **Cellular Responses:** - IP3 binds to receptors on the endoplasmic reticulum, causing the release of calcium ions (Ca2+) into the cytosol. Increased intracellular Ca2+ can lead to various cellular responses, such as muscle contraction, secretion, and changes in gene expression. - **DAG activates protein kinase C (PKC**), which phosphorylates various proteins, leading to a wide range of cellular responses. - α1-adrenergic receptors are found in various tissues throughout the body, including smooth muscle, heart muscle, and liver cells. - They play a role in a variety of physiological functions, including vasoconstriction, increased heart rate, and glucose release from the liver. - α1-adrenergic receptor antagonists, such as prazosin, are used to block the effects of NE on α1-adrenergic receptors and are used in the treatment of hypertension and other cardiovascular disorders. **Inhibition of Adenylyl Cyclase**: The activated Gi/Go protein inhibits the enzyme adenylyl cyclase. **Reduction of cAMP Levels**: Adenylyl cyclase is responsible for converting ATP into cyclic AMP (cAMP). Therefore, inhibition of adenylyl cyclase leads to a decrease in cAMP levels. **Reduction of cAMP-dependent Protein Kinase Activity:** cAMP acts as a second messenger to activate cAMP-dependent protein kinase (PKA). Reduced cAMP levels lead to decreased PKA activity. **Cellular Responses**: The specific cellular responses triggered by decreased PKA activity will vary depending on the cell type and the downstream targets of PKA. However, common effects include **reduced cell proliferation, decreased secretion, and changes in ion channel activity**. **β1-adrenergic receptor** **Activation of Adenylyl Cyclase**: The activated Gs protein stimulates the enzyme adenylyl cyclase. **Production of cAMP**: Adenylyl cyclase converts ATP into cyclic AMP (cAMP). **Activation of Protein Kinase A (PKA)**: cAMP binds to and activates PKA. **Cellular Responses**: Activated PKA phosphorylates various proteins within the cardiac muscle cell, leading to a number of effects: - Increased Ca2+ influx through L-type calcium channels - Increased release of Ca2+ from the sarcoplasmic reticulum - Phosphorylation of contractile proteins, leading to increased contractility - Phosphorylation of the β1-adrenergic receptor itself, leading to desensitization **β2-adrenergic receptor** **Activation of Adenylyl Cyclase**: The activated Gs protein stimulates the enzyme adenylyl cyclase. **Production of cAMP**: Adenylyl cyclase converts ATP into cyclic AMP (cAMP). **Activation of Protein Kinase A (PKA):** cAMP binds to and activates PKA. **Cellular Responses**: Activated PKA phosphorylates various proteins within the smooth muscle cell, leading to a number of effects: - Decreased Ca2+ influx through L-type calcium channels in the cell membrane - Increased Ca2+ uptake into the sarcoplasmic reticulum - Decreased actin-myosin interactions, leading to muscle relaxation